Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

shifting metabolome and

[1]  P. Bork,et al.  Enterotypes of the human gut mycobiome , 2022, bioRxiv.

[2]  R. Knight,et al.  Host variables confound gut microbiota studies of human disease , 2020, Nature.

[3]  Luis Pedro Coelho,et al.  Statin therapy is associated with lower prevalence of gut microbiota dysbiosis , 2020, Nature.

[4]  A. Kurilshikov,et al.  Impact of commonly used drugs on the composition and metabolic function of the gut microbiota , 2020, Nature Communications.

[5]  Luis Pedro Coelho,et al.  Extensive transmission of microbes along the gastrointestinal tract , 2018, bioRxiv.

[6]  Paul Theodor Pyl,et al.  Recovery of gut microbiota of healthy adults following antibiotic exposure , 2018, Nature Microbiology.

[7]  Luis Pedro Coelho,et al.  NG-meta-profiler: fast processing of metagenomes using NGLess, a domain-specific language , 2018, Microbiome.

[8]  Tiphaine Martin,et al.  Gut microbiota associations with common diseases and prescription medications in a population-based cohort , 2018, Nature Communications.

[9]  Peer Bork,et al.  Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.

[10]  P. Bork,et al.  The Human Gut Microbiome: From Association to Modulation , 2018, Cell.

[11]  A. Kurilshikov,et al.  Environment dominates over host genetics in shaping human gut microbiota , 2018, Nature.

[12]  Gabriel A. Al-Ghalith,et al.  Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications , 2018, Alimentary pharmacology & therapeutics.

[13]  Jun Wang,et al.  Quantitative microbiome profiling links gut community variation to microbial load , 2017, Nature.

[14]  Luis Pedro Coelho,et al.  Towards standards for human fecal sample processing in metagenomic studies , 2017, Nature Biotechnology.

[15]  C. Huttenhower,et al.  Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium , 2017, Nature Biotechnology.

[16]  Luis Pedro Coelho,et al.  metaSNV: A tool for metagenomic strain level analysis , 2017, PloS one.

[17]  Tatjana Schütz,et al.  Dietary Assessment in the MetaCardis Study: Development and Relative Validity of an Online Food Frequency Questionnaire. , 2017, Journal of the Academy of Nutrition and Dietetics.

[18]  David Torrents,et al.  Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug , 2017, Nature Medicine.

[19]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.

[20]  M. Bonder,et al.  The influence of proton pump inhibitors and other commonly used medication on the gut microbiota , 2017, Gut microbes.

[21]  Amy R. Cameron,et al.  Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status , 2016, Circulation research.

[22]  W. D. de Vos,et al.  Antibiotic use in childhood alters the gut microbiota and predisposes to overweight , 2016, Microbial cell.

[23]  J. Raes,et al.  Population-level analysis of gut microbiome variation , 2016, Science.

[24]  Martin J. Blaser,et al.  Antibiotic use and its consequences for the normal microbiome , 2016, Science.

[25]  Peer Bork,et al.  MOCAT2: a metagenomic assembly, annotation and profiling framework , 2016, Bioinform..

[26]  Jingyuan Fu,et al.  Proton pump inhibitors affect the gut microbiome , 2015, Gut.

[27]  Jun Wang,et al.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota , 2015, Nature.

[28]  Masahira Hattori,et al.  Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract , 2015, Clinical and Translational Gastroenterology.

[29]  M. Conlon,et al.  The Impact of Diet and Lifestyle on Gut Microbiota and Human Health , 2014, Nutrients.

[30]  S. Hazen,et al.  γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. , 2014, Cell metabolism.

[31]  Jens Roat Kultima,et al.  Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes , 2014, Nature Biotechnology.

[32]  Jens Roat Kultima,et al.  An integrated catalog of reference genes in the human gut microbiome , 2014, Nature Biotechnology.

[33]  M C M van Loosdrecht,et al.  Monitoring microbiological changes in drinking water systems using a fast and reproducible flow cytometric method. , 2013, Water research.

[34]  S. Brisse,et al.  AlienTrimmer: a tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads. , 2013, Genomics.

[35]  Alexandros Stamatakis,et al.  Metagenomic species profiling using universal phylogenetic marker genes , 2013, Nature Methods.

[36]  Mathieu Almeida,et al.  Dietary intervention impact on gut microbial gene richness , 2013, Nature.

[37]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[38]  Eric Verdin,et al.  Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.

[39]  F. Folli,et al.  The potential role of glutamate in the current diabetes epidemic , 2012, Acta Diabetologica.

[40]  M. Katz.  Multivariable Analysis: Contents , 2011 .

[41]  L. Keele,et al.  A General Approach to Causal Mediation Analysis , 2010, Psychological methods.

[42]  D. Schoeller.  The Challenge of Obesity in the WHO European Region and the Strategies for Response: Summary , 2008 .

[43]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[44]  Francesco Branca,et al.  The Challenge of Obesity in the WHO European Region and the Strategies for Response: Summary , 2007 .

[45]  Kurt Hornik,et al.  Introduction to arules – A computational environment for mining association rules and frequent item sets , 2009 .

[46]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[47]  A. Aljada,et al.  Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. , 2004, The Journal of clinical endocrinology and metabolism.

[48]  J. Hux,et al.  Quantifying the risk of infectious diseases for people with diabetes. , 2003, Diabetes care.

[49]  S. Ghosh,et al.  Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.

[50]  Falk Hildebrand,et al.  Enterotypes in the landscape of gut microbial community composition , 2017, Nature Microbiology.

[51]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[52]  W. Kerner,et al.  Definition, classification and diagnosis of diabetes mellitus. , 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[53]  T. Nijsten,et al.  Multivariable analysis. , 2014, The Journal of investigative dermatology.

[54]  Skipper Seabold,et al.  Statsmodels: Econometric and Statistical Modeling with Python , 2010, SciPy.